2024
Two NHS boards paused new puberty blockers and hormones for minors — existing patients were not taken off treatment.
What the law allows
Medical care for minorsRestricted
Restricted: NHS Greater Glasgow and Clyde and NHS Lothian paused new puberty blocker and cross-sex hormone prescriptions (April 2024).
NHS Greater Glasgow and Clyde — Service Update (18 April 2024)
Key dates2024
2024: Restricted: NHS Greater Glasgow and Clyde and NHS Lothian paused new puberty blocker and cross-sex hormone prescriptions (April 2024).
NHS Greater Glasgow and Clyde — Service Update (18 April 2024)
Official sources
NHS board pause on new puberty-suppressant and cross-sex hormone prescriptions.
Full official record
NHS Greater Glasgow and Clyde’s 18 April 2024 service update states that, on clinical advice, NHSGGC and NHS Lothian deferred new puberty-hormone-suppressant and cross-sex hormone starts in mid-March 2024 and then formally paused those treatments after the Cass Review, with existing patients continuing. The Scottish Government’s Cass implications report records that joint GGC/Lothian pause.
This is a public-board pause. Existing patients were not taken off treatment. The United Kingdom entry covers the UK-wide sale-and-supply order.